Standard treatment of chronic diabetic foot ulcers (DFU) is expensive and, for more than half of DFU patients, unsuccessful1. Health care policy decision makers should seek the most effec...
Purpose: Poloxamer 188* (P188) is a concentrated water-soluble hydrogel and surfactant used in the treatment of diabetic foot ulcerations. Hydrogels maintain moist environments while prom...
Problem: Diabetic foot ulceration (DFU) is a complication of diabetes that can lead to infection and/or amputation. DFU occurs in roughly 15 to 25% of patients with diabetes1. Recurrence...
Introduction:
Diabetic foot ulcers (DFUs) are an unfortunately common and grave complication of diabetes mellitus with up to 34% of people with diabetes potentially developing lower extr...
We present the first prospective multicenter randomized controlled trial evaluating the effects of Omega3 rich fish skin* for treatment of diabetic foot ulcers.
Introduction: Diabetic foot ulcers (DFUs) are a significant burden on the worldwide health-care system. These chronic lower extremity wounds are often refractory to standard of care and c...
Introduction: Advanced tissue matrices have shown promise for treating diabetic wounds and other soft tissue defects. Recent advancements in technology have led to the introduction of a n...
Background: The traditional Total Contact Cast (tTCC) has been used as the gold standard for treating diabetic foot ulcers (DFU). The application of tTCC is time consuming and requir...
Objective: Targeted, appropriate antimicrobials can prevent escalation to infection and future antibiotic necessity. Antimicrobial misuse often stems from diagnostic uncertainty duri...
Objective: The clinical evaluation of signs and symptoms (CSS) to determine a wound’s bacterial load and infection status is paramount to wound assessment.